Anthropic's $450M AI Funding Round Tops Crunchbase's Biggest Weekly Deals as Biotech Surges
Venture funding heated up this week with Anthropic clinching the largest round at $450 million in a Series C for its cutting-edge artificial intelligence efforts.
The San Francisco-based startup, known for its Claude AI assistant challenging ChatGPT dominance, attracted top-tier investors signaling robust confidence in AI's future.
Top Funding Rounds Spotlight
Led by Spark Capital with heavyweights like Google and Salesforce Ventures joining, Anthropic's raise pushes its total funding past $1.45 billion.
Biotech powerhouse ElevateBio followed closely with $401 million in Series D to advance gene therapy platforms and manufacturing innovations.
Newcomer ReNAgade Therapeutics launched with a massive $300 million Series A targeting RNA-based disease treatments from its Cambridge base.
Carmot Therapeutics secured $150 million in Series E for therapies combating obesity and diabetes, underscoring biotech's momentum.
Broader Impact and Future Outlook
These deals reflect a surge in investments into AI and biotech, potentially accelerating breakthroughs in intelligent systems and personalized medicine.
Historically, Anthropic built momentum from a $124 million Series A and $580 million Series B, navigating high-profile backers amid crypto fallout.
Looking forward, the capital infusion promises enhanced AI safety research and biotech scalability, shaping industries for years to come.
With venture activity ticking upward, investors eye sustained growth despite seasonal slowdowns.
